NRXS (STOCKS)
Neuraxis, Inc.
$4.924000
+0.304000 (+6.58%)
Prev close: $4.620000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Brian Carrico
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $54.76M
- Employees
- 21
- P/E (TTM)
- -4.55
- P/B (TTM)
- 20.02
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $3.36M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $526.32K |
| Costs And Expenses | $10.94M |
| Gross Profit | $2.84M |
| Operating Expenses | $10.42M |
| Depreciation and Amortization | $42.30K |
| Research and Development | $258.35K |
| Other Operating Expenses | $10.11M |
| Operating Income/Loss | -$7.58M |
| Income/Loss From Continuing Operations After Tax | -$7.54M |
| Income/Loss From Continuing Operations Before Tax | $3.36M |
| Interest Expense, Operating | -$124.36K |
| Net Income/Loss | -$7.54M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.54M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.33M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $786.16K |
| Preferred Stock Dividends And Other Adjustments | $786.16K |
| Basic Earnings Per Share | -$0.99 |
| Diluted Earnings Per Share | -$0.99 |
| Basic Average Shares | 8,687,132 |
| Diluted Average Shares | 8,687,132 |
| Assets | $5.78M |
| Current Assets | $4.99M |
| Inventory | $110.26K |
| Other Current Assets | $4.88M |
| Noncurrent Assets | $788.58K |
| Fixed Assets | $85.47K |
| Other Non-current Assets | $703.11K |
| Liabilities | $3.49M |
| Current Liabilities | $3.15M |
| Accounts Payable | $886.40K |
| Wages | $996.24K |
| Other Current Liabilities | $1.26M |
| Noncurrent Liabilities | $344.24K |
| Equity | $2.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.28M |
| Liabilities And Equity | $5.78M |
| Net Cash Flow From Operating Activities | -$6.26M |
| Net Cash Flow From Operating Activities, Continuing | -$6.26M |
| Net Cash Flow From Investing Activities | -$25.29K |
| Net Cash Flow From Investing Activities, Continuing | -$25.29K |
| Net Cash Flow From Financing Activities | $10.40M |
| Net Cash Flow From Financing Activities, Continuing | $10.40M |
| Net Cash Flow | $4.12M |
| Net Cash Flow, Continuing | $4.12M |
| Comprehensive Income/Loss | -$7.54M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.54M |
| Other Comprehensive Income/Loss | $0.00 |